Migden, M., Guminski, A., Gutzmer, R., Loquai, C., Squittieri, N., & Foley, P. . (2023). Hematology laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. SKIN The Journal of Cutaneous Medicine, 7(2), s180. https://doi.org/10.25251/skin.7.supp.180